A5001664608- Palliative Care and End-of-Life Issues
- Childhood Cancer Survivors' Quality of Life
- Cancer survivorship and care
- COVID-19 Clinical Research Studies
- Economic and Financial Impacts of Cancer
- Family and Patient Care in Intensive Care Units
- Nausea and vomiting management
- Health Systems, Economic Evaluations, Quality of Life
- Pharmacological Effects and Toxicity Studies
- Anesthesia and Pain Management
- Cancer Immunotherapy and Biomarkers
- SARS-CoV-2 and COVID-19 Research
- Intensive Care Unit Cognitive Disorders
- Advances in Oncology and Radiotherapy
- Pathogenesis and Treatment of Hiccups
- Cancer Treatment and Pharmacology
- Lipoproteins and Cardiovascular Health
- Nutrition and Health in Aging
- Pancreatitis Pathology and Treatment
- Respiratory Support and Mechanisms
- COVID-19 and healthcare impacts
- Clinical practice guidelines implementation
- Healthcare Decision-Making and Restraints
- Vitamin C and Antioxidants Research
- Neutropenia and Cancer Infections
Yale University
2020-2025
Yale Cancer Center
2021-2024
Smilow Cancer Hospital
2021-2023
Yale New Haven Hospital
2021-2023
Yale New Haven Health System
2021
Brown University
2015-2019
Miriam Hospital
2016
Rhode Island Hospital
2016
John Brown University
2014
PURPOSE Immune checkpoint inhibitors (ICIs) have revolutionized the care of patients with cancer, but use among hospitalized is controversial as a result questionable benefit and high costs. To evaluate role ICIs in inpatient (IP) setting, we conducted Inpatient Immunotherapy Outcomes Study (IIOS) to describe characteristics outcomes who received IP ICIs. METHODS IIOS retrospective study treated during hospitalization between 2012 2021 at five academic institutions. Data collection was...
Live hospice discharges represent a potential vulnerability in the Medicare benefit. Little is known about how live have varied over time. To identify trends between 2000 and 2012. Retrospective cohort study of discharges. In this study, we examined first six months 2000, 2006, 2008, 2010, A discharge was classified as burdensome transition if followed by hospital admission, then there readmission within 2 days discharge. The adjusted rate overall transitions with multivariate mixed-effects...
Smilow Cancer Hospital (SCH) introduced hospitalist comanagement to the inpatient oncology service address long lengths of stay and oncologist burnout.To determine impact hospitalists on quality outcomes experience.Hospitalists were one two services at SCH. Patients assigned teams equally based capacity. Outcomes oncologist-led, traditional (TS) compared with (HS) 6 months after program implementation.Outcomes included patient volume, length (LOS), early discharge, discharge time, 30-day...
Abstract Background Palliative treatment has been associated with improved quality of life and survival for a wide variety metastatic cancers. However, it is unclear whether the benefits palliative are uniformly experienced across US cancer population. We evaluated patterns outcomes based on socioeconomic, sociodemographic treating facility characteristics. Methods Patients diagnosed between 2008 2019 Stage IV primary nine organ sites were analyzed in National Cancer Database. The...
High-intensity end-of-life (EOL) care, marked by admission to intensive care units (ICUs) or in-hospital death, can be costly and burdensome. Recent trends in use of ICUs, life-sustaining treatments (LSTs), noninvasive ventilation (NIV) during EOL hospitalizations among older adults with advanced cancer patterns death are unknown.
Objectives We aimed to explore the association between receiving an inpatient palliative care consultation and hospital outcomes, including in-hospital death, intensive unit (ICU) use, discharge hospice, 30-day readmissions emergency department (ED) visits. Methods conducted a retrospective chart review of Yale New Haven Hospital medical oncology admissions from January 2018 through December 2021, with without consultations. outcome data were extracted records operationalised as binary....
BACKGROUND Acquired Factor (F)XIII deficiency is a very rare bleeding diathesis with potentially fatal outcome, previously described in the context of autoimmune disorders and leukemias. There minimal information on autoantibody characterization role antifibrinolytic therapy patient management. CASE REPORT A 79‐year‐old woman 3‐month history bruising heavy menorrhagia presented ongoing vaginal bleeding, symptomatic anemia, right thigh hematoma. Initial management included an axillary lymph...
Background: A recent systematic review and meta-analysis reporting on thirteen published cohorts investigating 110,078 patients demonstrated that who were administered statins after their COVID-19 diagnosis hospitalization had a lower risk of mortality. While these findings are encouraging, given competing treatment approaches, it is unclear if statin use should be prioritized its cost-effective options for hospitalized patients. In this study, we report cost-effectiveness analysis...